Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Meryl, Brod"'
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-17 (2024)
Abstract Background Hypoparathyroidism is a rare endocrine disease frequently associated with serious physical and cognitive symptoms. This study’s purpose was to understand the impacts of the phase 3 PaTHway clinical trial treatment, TransCon PTH,
Externí odkaz:
https://doaj.org/article/ed6cfc5871df46fa8dc3320fb0ae366c
Autor:
Meryl Brod, Donald M. Bushnell, Jesper Skov Neergaard, Laura Tesler Waldman, Anne Kirstine Busk
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-23 (2023)
Abstract Background To capture the broad range of treatment burden issues experienced by adolescent and adult people with hemophilia (PWH), the Hemophilia Treatment Experience Measure (Hemo-TEM) was developed. We describe the development of this new
Externí odkaz:
https://doaj.org/article/2ff47f0b4b2047fe8f4f7be1ab2f040e
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background Currently, there is limited research on how having a child diagnosed with achondroplasia affects parents’ lives. The purpose of the study was to investigate the experiences of parents of infants and young children less than two
Externí odkaz:
https://doaj.org/article/474a802f24fb470996c83ae5a36f1667
Autor:
Meryl Brod, Lori McLeod, Denka Markova, Jill Gianettoni, Sanchita Mourya, Zhengning Lin, Aimee Shu, Alden Smith
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-19 (2021)
Abstract Background Hypoparathyroidism (HP) is a rare endocrine disorder characterized by absent or inappropriately low levels of circulating parathyroid hormone with associated significant physical and cognitive symptoms. This study evaluated the ps
Externí odkaz:
https://doaj.org/article/39197a492a4d4c998bb68870159065ce
Publikováno v:
BMJ Open Quality, Vol 11, Iss 3 (2022)
Background Spine pain is one of the most common conditions seen in primary care and is often treated with ineffective, aggressive interventions, such as prescription pain medications, imagery and referrals to surgery. Aggressive treatments are associ
Externí odkaz:
https://doaj.org/article/9ee13f565df248e5869f72252e95cce9
Autor:
Laura Tesler Waldman, Sairam Parthasarathy, Kathleen F. Villa, Morgan Bron, Shay Bujanover, Meryl Brod
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background Obstructive sleep apnea (OSA) is associated with excessive daytime sleepiness (EDS), which may go undiagnosed and can significantly impair a patient’s health-related quality of life (HRQOL). This qualitative research examined ti
Externí odkaz:
https://doaj.org/article/5c5af6ecefb741ba9046f288fc1a782a
Publikováno v:
Quality of Life Research. 32:1795-1806
Purpose The purpose of this study was to conduct cognitive debriefing (CD) interviews with adults diagnosed with chronic hypoparathyroidism (HP) to assess the content validity of the SF-36v2® Health Survey Acute (SF-36v2) measure in this population.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5fb843b85572078d713c621e813c1bf
https://doi.org/10.1007/s11136-023-03352-x
https://doi.org/10.1007/s11136-023-03352-x
Autor:
Meryl Brod, Lise Højbjerre, Kathryn M. Pfeiffer, Robyn Sayner, Henrik H. Meincke, Donald L. Patrick
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-12 (2018)
Abstract Background Overweight and obesity have been associated with physical and emotional signs & symptoms. Research has shown that modest weight loss can mitigate some symptoms in individuals with overweight or obesity. This study’s purpose was
Externí odkaz:
https://doaj.org/article/67e2281da259494aa6c3d7c6cf7fd0c0
Autor:
Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, Jane F. Beck, Donald M. Bushnell, Kai Wai Lee, Aristides Maniatis
Publikováno v:
PharmacoEconomics - Open. 7:121-138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99217914e161218c1d0a3694696ab562
https://doi.org/10.1007/s41669-022-00373-z
https://doi.org/10.1007/s41669-022-00373-z
Autor:
Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, Meryl Brod, Sebastian Röhrich, Paul Saenger, Reiko Horikawa
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Growth hormone deficiency (GHD) in children is currently treated with daily injections of GH, which can be burdensome for patients and their parents/guardians. Somapacitan is a GH derivative in development for once-weekly treatment of GHD. Ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::589bbec08038f93791e7a4e153112058
https://doi.org/10.1210/clinem/dgad183
https://doi.org/10.1210/clinem/dgad183